Khalid Alyahyawi

Dr. Khalid Alyahyawi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2024 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
AAAbdulaziz A Arishi
Abdulaziz A Arishi
IHIbrahim Ali Hakami
Ibrahim Ali Hakami
HMHassan N. Mashbari
Hassan N. Mashbari
AHAlhassan Hassan Hobani
Alhassan Hassan Hobani
HAHafiz Ismail Al-Musawa
Hafiz Ismail Al-Musawa
KAKhalid Alyahyawi
Khalid Alyahyawi

4 September 2024 in Journal of Robotic Surgery
Verified
Journal Article
Open access
PDF file
AAAbdulaziz A Arishi
Abdulaziz A Arishi
IHIbrahim Ali Hakami
Ibrahim Ali Hakami
HMHassan N. Mashbari
Hassan N. Mashbari
AHAlhassan Hassan Hobani
Alhassan Hassan Hobani
HAHafiz Ismail Al-Musawa
Hafiz Ismail Al-Musawa
KAKhalid Alyahyawi
Khalid Alyahyawi

29 April 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
KAKhalid Alyahyawi
Khalid Alyahyawi
Intestinal tuberculosis (ITB) is a complex form of extrapulmonary tuberculosis characterized by nonspecific gastrointestinal symptoms and substantial overlap with conditions such as Crohn’s disease and gastrointestinal malignancies. These similarities frequently lead to diagnostic uncertainty, delayed diagnosis, and inappropriate management. This systematic review summarizes current evidence on the clinical presentation, diagnostic approaches, and therapeutic strategies for ITB, with particular emphasis on emerging diagnostic technologies and their role in reducing surgical interventions. A systematic literature search was conducted using PubMed, Scopus, and Google Scholar following PRISMA guidelines to identify relevant studies published from 2000 to 2025. The review focused on clinical manifestations, imaging findings, endoscopic features, histopathological characteristics, molecular diagnostics, pharmacological therapy, and minimally invasive therapeutic interventions. Accurate diagnosis requires an integrated approach combining clinical assessment with imaging, endoscopic evaluation, and histopathological confirmation. Molecular techniques such as GeneXpert MTB/RIF and GeneXpert MTB/RIF Ultra and multiplex polymerase chain reaction assays improve diagnostic accuracy and shorten detection time. Emerging technologies including artificial intelligence-assisted radiologic interpretation and CRISPR-based stool sequencing platforms show promise for earlier detection. Standard anti-tubercular therapy remains the cornerstone of treatment, while minimally invasive endoscopic and surgical procedures are effective for managing complications such as strictures, obstruction, and perforation. Early and precise diagnosis of intestinal tuberculosis is essential to prevent complications and optimize patient outcomes. Integrating conventional diagnostic approaches with emerging molecular and artificial intelligence-based technologies may enhance diagnostic precision and support individualized treatment strategies. Further ITB-specific clinical studies are needed to validate novel diagnostic tools and refine therapeutic approaches for improved patient care.